Dr Assadour Assadourian, MD | |
6200 I-40 W, Amarillo, TX 79106-2512 | |
(806) 354-9764 | |
(806) 355-2868 |
Full Name | Dr Assadour Assadourian |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 33 Years |
Location | 6200 I-40 W, Amarillo, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912952581 | NPI | - | NPPES |
150955603 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | L3562 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Baptist St Anthony's Hospital | Amarillo, TX | Hospital |
Northwest Texas Hospital | Amarillo, TX | Hospital |
Memorial Hospital | Dumas, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northwest Texas Healthcare System Inc | 0941106363 | 23 |
Bsa Hospital Llc | 6305090762 | 22 |
Cardiology Center Of Amarillo | 9234036013 | 16 |
News Archive
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy.
The humble aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great promise to be, not only an extremely potent cancer-fighter, but even safer than the classic medicine cabinet staple.
The cannabinoid receptors best known for delivering the psychological effects of marijuana also explain the connection between chronic alcohol use and a buildup of fat in the liver, according to a report in the March issue of Cell Metabolism, a publication of Cell Press.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
› Verified 7 days ago
Entity Name | Cardiology Center Of Amarillo |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376598771 PECOS PAC ID: 9234036013 Enrollment ID: O20031218000641 |
News Archive
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy.
The humble aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great promise to be, not only an extremely potent cancer-fighter, but even safer than the classic medicine cabinet staple.
The cannabinoid receptors best known for delivering the psychological effects of marijuana also explain the connection between chronic alcohol use and a buildup of fat in the liver, according to a report in the March issue of Cell Metabolism, a publication of Cell Press.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
› Verified 7 days ago
Entity Name | Northwest Texas Healthcare System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154347987 PECOS PAC ID: 0941106363 Enrollment ID: O20040123000725 |
News Archive
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy.
The humble aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great promise to be, not only an extremely potent cancer-fighter, but even safer than the classic medicine cabinet staple.
The cannabinoid receptors best known for delivering the psychological effects of marijuana also explain the connection between chronic alcohol use and a buildup of fat in the liver, according to a report in the March issue of Cell Metabolism, a publication of Cell Press.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
› Verified 7 days ago
Entity Name | Bsa Hospital Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609112069 PECOS PAC ID: 6305090762 Enrollment ID: O20130212000300 |
News Archive
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy.
The humble aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great promise to be, not only an extremely potent cancer-fighter, but even safer than the classic medicine cabinet staple.
The cannabinoid receptors best known for delivering the psychological effects of marijuana also explain the connection between chronic alcohol use and a buildup of fat in the liver, according to a report in the March issue of Cell Metabolism, a publication of Cell Press.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Assadour Assadourian, MD 6200 I-40 W, Amarillo, TX 79106-2512 Ph: (806) 354-9764 | Dr Assadour Assadourian, MD 6200 I-40 W, Amarillo, TX 79106-2512 Ph: (806) 354-9764 |
News Archive
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy.
The humble aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great promise to be, not only an extremely potent cancer-fighter, but even safer than the classic medicine cabinet staple.
The cannabinoid receptors best known for delivering the psychological effects of marijuana also explain the connection between chronic alcohol use and a buildup of fat in the liver, according to a report in the March issue of Cell Metabolism, a publication of Cell Press.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
› Verified 7 days ago
James Edward Lusby, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6700 W 9th Ave, Amarillo, TX 79106 Phone: 806-358-0200 Fax: 806-356-5590 | |
Henry David Bruton, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6700 W 9th Ave, Amarillo, TX 79106 Phone: 806-358-0200 Fax: 806-356-5511 | |
Dr. Anjali Subhash Kherdekar, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 12 Care Cir, Amarillo, TX 79124 Phone: 806-353-7417 Fax: 806-353-4007 | |
James P.a. Yhip, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1660 Point West Pkwy, Amarillo, TX 79124 Phone: 806-510-4244 Fax: 806-510-7211 | |
Dr. Michael John Lamanteer, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1600 Wallace Blvd, Amarillo, TX 79106 Phone: 806-212-2129 Fax: 806-212-2246 | |
Thien Toan Vo, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 S Coulter St, Amarillo, TX 79106 Phone: 806-414-9100 Fax: 806-354-5717 | |
John Scott Milton, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1400 S Coulter St, Amarillo, TX 79106 Phone: 806-354-5480 Fax: 806-354-5764 |